Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis

被引:51
作者
Brebion, Franck [1 ]
Gosmini, Romain [1 ]
Deprez, Pierre [1 ]
Varin, Marie [1 ]
Peixoto, Christophe [1 ]
Alvey, Luke [1 ]
Jary, Helene [1 ]
Bienvenu, Natacha [1 ]
Triballeau, Nicolas [1 ]
Blanque, Roland [1 ]
Cottereaux, Celine [1 ]
Christophe, Thierry [2 ]
Vandervoort, Nele [2 ]
Mollat, Patrick [1 ]
Touitou, Robert [1 ]
Leonard, Philip [3 ]
De Ceuninck, Frederic [4 ]
Botez, Iuliana [5 ]
Monjardet, Alain [1 ]
van der Aar, Ellen [2 ]
Amantini, David [1 ]
机构
[1] Galapagos SASU, F-93230 Romainville, France
[2] Galapagos NV, B-2800 Mechelen, Belgium
[3] Charles River, Struct Biol, Saffron Walden CB10 1XL, Essex, England
[4] Inst Rech Servier, Ctr Therapeut Innovat, Immunoinflammatory Dis, F-78290 Croissy Sur Seine, France
[5] Inst Rech Servier, Chem Ctr Excellence, F-78290 Croissy Sur Seine, France
关键词
D O I
10.1021/acs.jmedchem.0c02008
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
There are currently no approved disease-modifying osteoarthritis (OA) drugs (DMOADs). The aggrecanase ADAMTS-5 is key in the degradation of human aggrecan (AGC), a component of cartilage. Therefore, ADAMTS-5 is a promising target for the identification of DMOADs. We describe the discovery of GLPG1972/S201086, a potent and selective ADAMTS-5 inhibitor obtained by optimization of a promising hydantoin series following an HTS. Biochemical activity against rat and human ADAMTS-5 was assessed via a fluorescence-based assay. ADAMTS-5 inhibitory activity was confirmed with human aggrecan using an AGC ELISA. The most promising compounds were selected based on reduction of glycosaminoglycan release after interleukin-1 stimulation in mouse cartilage explants and led to the discovery of GLPG1972/S201086. The anticatabolic activity was confirmed in mouse cartilage explants (IC50 < 1.5 mu M). The cocrystal structure of GLPG1972/S201086 with human recombinant ADAMTS-5 is discussed. GLPG1972/S201086 has been investigated in a phase 2 clinical study in patients with knee OA (NCT03595618).
引用
收藏
页码:2937 / 2952
页数:16
相关论文
共 36 条
[1]
ADAMTS5-/- mice have less subchondral bone changes after induction of osteoarthritis through surgical instability: implications for a link between cartilage and subchondral bone changes [J].
Botter, S. M. ;
Glasson, S. S. ;
Hopkins, B. ;
Clockaerts, S. ;
Weinans, H. ;
van Leeuwen, J. P. T. M. ;
van Osch, G. J. V. M. .
OSTEOARTHRITIS AND CARTILAGE, 2009, 17 (05) :636-645
[2]
Computation of octanol-water partition coefficients by guiding an additive model with knowledge [J].
Cheng, Tiejun ;
Zhao, Yuan ;
Li, Xun ;
Lin, Fu ;
Xu, Yong ;
Zhang, Xinglong ;
Li, Yan ;
Wang, Renxiao ;
Lai, Luhua .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2007, 47 (06) :2140-2148
[3]
Elevated aggrecanase activity in a rat model of joint injury is attenuated by an aggrecanase specific inhibitor [J].
Chockalingam, P. S. ;
Sun, W. ;
Rivera-Bermudez, M. A. ;
Zeng, W. ;
Dufield, D. R. ;
Larsson, S. ;
Lohmander, L. S. ;
Flannery, C. R. ;
Glasson, S. S. ;
Georgiadis, K. E. ;
Morris, E. A. .
OSTEOARTHRITIS AND CARTILAGE, 2011, 19 (03) :315-323
[4]
MolProbity: all-atom contacts and structure validation for proteins and nucleic acids [J].
Davis, Ian W. ;
Leaver-Fay, Andrew ;
Chen, Vincent B. ;
Block, Jeremy N. ;
Kapral, Gary J. ;
Wang, Xueyi ;
Murray, Laura W. ;
Arendall, W. Bryan, III ;
Snoeyink, Jack ;
Richardson, Jane S. ;
Richardson, David C. .
NUCLEIC ACIDS RESEARCH, 2007, 35 :W375-W383
[5]
Discovery of Highly Potent and Selective Small Molecule ADAMTS-5 Inhibitors That Inhibit Human Cartilage Degradation via Encoded Library Technology (ELT) [J].
Deng, Hongfeng ;
O'Keefe, Heather ;
Davie, Christopher P. ;
Lind, Kenneth E. ;
Acharya, Raksha A. ;
Franklin, G. Joseph ;
Larkin, Jonathan ;
Matico, Rosalie ;
Neeb, Michael ;
Thompson, Monique M. ;
Lohr, Thomas ;
Gross, Jeffrey W. ;
Centrella, Paolo A. ;
O'Donovan, Gary K. ;
Bedard, Katie L. ;
van Vloten, Kurt ;
Mataruse, Sibongile ;
Skinner, Steven R. ;
Belyanskaya, Svetlana L. ;
Carpenter, Tiffany Y. ;
Shearer, Todd W. ;
Clark, Matthew A. ;
Cuozzo, John W. ;
Arico-Muendel, Christopher C. ;
Morgan, Barry A. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7061-7079
[6]
A Highly Selective Hydantoin Inhibitor of Aggrecanase-1 and Aggrecanase-2 with a Low Projected Human Dose [J].
Durham, Timothy B. ;
Marimuthu, Jothirajah ;
Toth, James L. ;
Liu, Chin ;
Adams, Lisa ;
Mudra, Daniel R. ;
Swearingen, Craig ;
Lin, Chaohua ;
Chambers, Mark G. ;
Thirunavukkarasu, Kannan ;
Wiley, Michael R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) :5933-5939
[7]
High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells [J].
Durocher, Y ;
Perret, S ;
Kamen, A .
NUCLEIC ACIDS RESEARCH, 2002, 30 (02) :E9
[8]
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma [J].
Fields, Gregg B. .
CELLS, 2019, 8 (09)
[9]
Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis [J].
Glasson, SS ;
Askew, R ;
Sheppard, B ;
Carito, B ;
Blanchet, T ;
Ma, HL ;
Flannery, CR ;
Peluso, D ;
Kanki, K ;
Yang, ZY ;
Majumdar, MK ;
Morris, EA .
NATURE, 2005, 434 (7033) :644-648
[10]
Association of ADAMTS5 gene polymorphisms with osteoarthritis in Chinese Han population: a community-based case-control study [J].
Gu, Jiaao ;
Rong, Jiesheng ;
Guan, Fulin ;
Jiang, Liying ;
Zhang, Ting ;
Tao, Shuqing ;
Guan, Guofa ;
Xu, Liang ;
Tao, Tianzun .
RHEUMATOLOGY INTERNATIONAL, 2013, 33 (11) :2893-2897